Table 2 General sequence and results obtained of the synthesis of the ChAgG nanocomposites.

From: Antibacterial nanocomposite of chitosan/silver nanocrystals/graphene oxide (ChAgG) development for its potential use in bioactive wound dressings

1. TGA

2. XRD

3. SEM

Higher residual mass (~ 5%) obtained from garlic source than onion in AgNCs synthesis

Crystalline cubic structure of AgNCs

A5’s sample showed the highest crystallinity

384.6 ± 168.2 nm conglomerate’s crystals size

4. HRTEM

5. Raman

6. XPS

5.6 ± 1.5 nm particle size of AgNCs

Evidence is given in the oxidation of graphene by conventional microwaves and the generation of defects by the generation of the ChAgG nanocomposite

AgNCs present in the ChAgG nanocomposite and it is interacting with oxygen atom of the GrOx and chitosan

7. Antibacterial bioactivity

8. In vitro biocompatibility

Highest bioactivity was observed with just 3.125 µg/mL of the ChAgG nanocomposite reducing bacterial population about ~ 52, 54, and 62% at 24, 48 and 72 h, respectively

Almost no alteration (ANOVA P > 0.05) in cell growth was observed between concentrations of 50–3.125 µg/mL

Back to article page